Search

everythinglearnresearchcommunity

for

Search:↓

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Infrared light might help treat stubborn alopecia areata.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

A new patch can deliver stable antibodies over time for potential HIV treatment.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Applying thyroid hormone T3 speeds up wound healing in mice.

Tofacitinib may help regrow hair in alopecia areata patients.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

CS12192 effectively treats alopecia areata with better safety than current options.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Most patients with Tuberous sclerosis had neurological or skin issues, and over half had psychiatric problems.

Ayurvedic treatments may help reduce hypothyroidism symptoms.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Levothyroxine is less effective in men with early-onset male-pattern baldness.

A cream with a specific hormone blocker increases hair growth in mice.

Blue-light activation of TrkA improves hair-follicle stem cells' ability to become neurons and glial cells.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.